Home Cart Sign in  
Chemical Structure| 164650-44-6 Chemical Structure| 164650-44-6

Structure of Efinaconazole
CAS No.: 164650-44-6

Chemical Structure| 164650-44-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Efinaconazole is a triazole antifungal used to treat for onychomycosis, as it is a 14 alpha-demethylase inhibitor.

Synonyms: KP-103

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Efinaconazole

CAS No. :164650-44-6
Formula : C18H22F2N4O
M.W : 348.39
SMILES Code : C[C@@H](N1CCC(CC1)=C)[C@@](O)(C2=CC=C(F)C=C2F)CN3N=CN=C3
Synonyms :
KP-103
MDL No. :MFCD00936407
InChI Key :NFEZZTICAUWDHU-RDTXWAMCSA-N
Pubchem ID :489181

Safety of Efinaconazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H361
Precautionary Statements:P201-P202-P280-P308+P313-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Candida albicans 0.002 mg/ml 24 hours Evaluate the in vitro antifungal activity of KP-103 against Candida albicans, showing that KP-103 was the most active among all tested drugs. Antimicrob Agents Chemother. 2001 May;45(5):1493-9.
Malassezia furfur 0.025 mg/ml 5 days Evaluate the in vitro antifungal activity of KP-103 against Malassezia furfur, showing that KP-103 was the most active among all tested drugs. Antimicrob Agents Chemother. 2001 May;45(5):1493-9.
Trichophyton mentagrophytes (in keratin-containing medium) 5 μg/mL and 20 μg/mL 3, 7, 10, and 14 days To evaluate the fungicidal activity of Efinaconazole against T. mentagrophytes in keratin-containing medium. The results showed that Efinaconazole exhibited potent fungicidal activity at 5 μg/mL and 20 μg/mL in a time-dependent manner, resulting in complete mycological eradication on Day 14 and Day 7, respectively. J Fungi (Basel). 2017 Oct 19;3(4):58
Trichophyton rubrum 0.0020–0.0078 μg/mL 4 days To determine the minimum inhibitory concentration (MIC) of Efinaconazole against T. rubrum. The results showed that the MIC range was 0.0020–0.0078 μg/mL, with an MIC90 value of 0.0078 μg/mL. J Fungi (Basel). 2017 Oct 19;3(4):58
Trichophyton rubrum 0.002 to 0.063 μg/ml 96 hours To evaluate the in vitro antifungal activity of Efinaconazole against Trichophyton rubrum, showing significant inhibitory effects with MIC50 of 0.004 μg/ml and MIC90 of 0.008 μg/ml. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02423-17
Trichophyton interdigitale 0.002 to 0.063 μg/ml 96 hours To evaluate the in vitro antifungal activity of Efinaconazole against Trichophyton interdigitale, showing significant inhibitory effects with MIC50 of 0.008 μg/ml and MIC90 of 0.016 μg/ml. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02423-17
Trichophyton rubrum BR1A 0.320 mg/mL 72 hours To evaluate the damaging effect of Efinaconazole on clinical strain BR1A biofilms, results showed Efinaconazole significantly reduced hyphal density and biofilm thickness. J Fungi (Basel). 2017 May 5;3(2):20
Non-Fusarium solani species complex (non-FSSC) 0.25~4 mg/L 48 hours To determine the minimal inhibitory concentration (MIC) of Efinaconazole against non-FSSC, the results showed a GM MIC of 0.46 mg/L. J Fungi (Basel). 2022 May 3;8(5):476
Fusarium solani species complex (FSSC) 0.5~2 mg/L 48 hours To determine the minimal inhibitory concentration (MIC) of Efinaconazole against FSSC, the results showed a GM MIC of 1.15 mg/L. J Fungi (Basel). 2022 May 3;8(5):476
Trichophyton mentagrophytes 0.0039–0.031 μg/mL 4 days To determine the minimum inhibitory concentration (MIC) of Efinaconazole against T. mentagrophytes. The results showed that the MIC range was 0.0039–0.031 μg/mL, with an MIC90 value of 0.016 μg/mL. J Fungi (Basel). 2017 Oct 19;3(4):58
Scopulariopsis brevicaulis 0.156 mg/liter 72 hours Evaluate the antifungal activity of Efinaconazole against S. brevicaulis Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00442-19
Candida parapsilosis 0.078 or 0.156 mg/liter 48 hours Evaluate the antifungal activity of Efinaconazole against C. parapsilosis Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00442-19
Trichophyton rubrum 0.0025 mg/liter 48 hours Evaluate the antifungal activity and potential to induce resistance of Efinaconazole against T. rubrum Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00442-19
Trichophyton interdigitale 0.000061–0.063 µg/mL 4 days Evaluate the combined antifungal effect of Efinaconazole with terbinafine, showing synergistic effects on 43.8% of the strains J Fungi (Basel). 2021 Mar 12;7(3):208
Saprophytic fungi 0.0078-1 µg/mL 48 hours Evaluate the in vitro antifungal activity of Efinaconazole against saprophytic fungi, showing high susceptibility. Front Cell Infect Microbiol. 2021 Jul 15;11:693522
Dermatophytes 0.0625-0.0156 µg/mL 48 hours Evaluate the in vitro antifungal activity of Efinaconazole against dermatophytes, showing high susceptibility. Front Cell Infect Microbiol. 2021 Jul 15;11:693522
Candida species 0.0078-0.5 µg/mL 48 hours Evaluate the in vitro antifungal activity of Efinaconazole against Candida species, showing high susceptibility. Front Cell Infect Microbiol. 2021 Jul 15;11:693522
bovine hoof slices 10% w/w 20 hours Evaluate the effect of different penetration enhancers on the permeation of Efinaconazole through bovine hoof slices. Results showed that the L-HS3 formulation containing Labrafac PG had 41% higher permeation than the HS base. Molecules. 2021 Mar 16;26(6):1650
Trichophyton rubrum BR1A 0.320 mg/mL 72 hours To evaluate the damaging effect of Efinaconazole on clinical strain BR1A biofilms, results showed Efinaconazole significantly reduced hyphal density and biofilm thickness. Front Cell Infect Microbiol. 2021 Jul 15;11:684150
Trichophyton rubrum ATCC MYA-4438 0.320 mg/mL 72 hours To evaluate the damaging effect of Efinaconazole on Trichophyton rubrum biofilms, results showed Efinaconazole significantly damaged biofilm structure, causing collapse of hyphal cell walls. Front Cell Infect Microbiol. 2021 Jul 15;11:684150

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Guinea pigs (Hartley strain) T. mentagrophytes-infected guinea pig onychomycosis model Topical application 10% EFN solution Once daily for 4 weeks To evaluate the in vivo antifungal efficacy of EFN-J and EFN-K in the T. mentagrophytes-infected guinea pig onychomycosis model. EFN-K significantly reduced the mean viable fungal cell count by 54.3% and accelerated the structural recovery of the keratin layer. Drug Deliv. 2019 Dec;26(1):1167-1177
Guinea pigs Guinea pig onychomycosis model Topical application 10% solution Once daily for four weeks To evaluate the therapeutic efficacy of Efinaconazole 10% solution in a guinea pig onychomycosis model. The results showed that Efinaconazole significantly reduced viable cell counts (1.80 ± 0.66 Log CFU/foot), which was significantly better than tavaborole 5% solution (2.94 ± 0.42 Log CFU/foot) and ciclopirox 8% nail lacquer (2.78 ± 0.73 Log CFU/foot). J Fungi (Basel). 2017 Oct 19;3(4):58

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02812771 Onychomycosis PHASE4 COMPLETED 2019-01-14 Valeant Site 01, Birmingham, A... More >>labama, 35201, United States|Valeant Site 04, Fountain Valley, California, 92708, United States|Valeant Site 03, Santa Rosa, California, 95403, United States|Valeant SIte 05, South Miami, Florida, 33143, United States|Valeant Site 09, New Orleans, Louisiana, 70130, United States|Valeant Site 08, Baltimore, Maryland, 21214, United States|Valeant Site 02, Forest Hills, New York, 11375, United States|Valeant Site 06, Philadelphia, Pennsylvania, 19107, United States|Valeant Site 07, McAllen, Texas, 78501, United States|Valeant Site 10, Santo Domingo, Dominican Republic Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.87mL

0.57mL

0.29mL

14.35mL

2.87mL

1.44mL

28.70mL

5.74mL

2.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories